Kamakura, Japan

Tadamasa Arai




Average Co-Inventor Count = 7.1

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2012-2019

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Tadamasa Arai: Innovator in Pain Management

Introduction

Tadamasa Arai is a notable inventor based in Kamakura, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address pain management. With a total of 3 patents, Arai's work focuses on innovative solutions for neuropathic pain and fibromyalgia syndrome.

Latest Patents

Arai's latest patents include a cyclic amine derivative that exerts an analgesic effect against pain, specifically targeting neuropathic pain and fibromyalgia syndrome. This compound is represented by a general formula and includes pharmacologically acceptable salts. Another significant patent is for a cyclohexane derivative, which provides relief for both nociceptive and neuropathic pain while minimizing side effects. This compound also encompasses pharmaceutically acceptable salts and prodrugs.

Career Highlights

Arai is currently associated with Toray Industries, Inc., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing pain management therapies, making a positive impact on patients suffering from chronic pain conditions.

Collaborations

Arai collaborates with esteemed colleagues such as Yasuhiro Morita and Katsuhiko Iseki, contributing to a dynamic research environment that fosters innovation and development in pharmaceutical applications.

Conclusion

Tadamasa Arai's contributions to pain management through his innovative patents highlight his role as a key inventor in the pharmaceutical industry. His work continues to pave the way for effective treatments that improve the quality of life for many individuals suffering from pain.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…